<DOC>
	<DOCNO>NCT00267371</DOCNO>
	<brief_summary>The purpose two arm control double-blind study determine safety effectiveness PFO closure ( close hole wall heart ) reduce frequency migraine headache , patient experience migraine headache PFO , compare medical therapy alone .</brief_summary>
	<brief_title>ESCAPE Migraine Trial</brief_title>
	<detailed_description>Migraine headache neurological disorder characterize chronic disabling headache . Approximately 10-12 % human , comprise 28 million Americans , suffer disorder . Despite continual advance medical management migraine , many sufferer continue experience frequent disable attack despite appropriate medical therapy . Preventative medication , anti-epileptic drug , anti-depressants , beta-blockers , effective many patient , side-effect profile preclude use many patient . In past decade , grow evidence patient migraine , particularly aura , likely patent foramen ovale . A patent foramen ovale ( PFO ) persistent , flap-like opening wall heart , right leave atrium . Typically , open close shortly birth , however , people , remain open . While currently proof cause-effect relationship , several recent study confirm strong association presence PFO migraine aura . Comparison : This clinical study compare PFO closure medical therapy alone treatment migraine headache .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects , Atrial</mesh_term>
	<criteria>Major Patient must age 18 70 ; Patient must migraine history demonstrate refractoriness medical treatment ; Patient must Patent Foramen Ovale ( PFO ) ; Patient must willing able give inform consent complete require followup visit . Major Patient medical condition receives medication would preclude participation trial Patient enrol intend participate another clinical study ( investigational drug device , new indication approve drug device , requirement additional test beyond standard clinical practice ) study within four week prior his/her enrollment study . Patient pregnant , intend become pregnant trial period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Migraine headache</keyword>
	<keyword>Patent Foramen Ovale</keyword>
	<keyword>Patent Foramen Ovale Closure</keyword>
</DOC>